
TVA Medical closes $15M Series C for device designed for end-stage renal disease
Investment driven from Baxter Ventures and Boston Scientific Corporation has brought TVA Medical up by $15 million.
Investment driven from Baxter Ventures and Boston Scientific Corporation has brought TVA Medical up by $15 million.